2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses the importance on efforts being done to prevent gynecologic cancers.
Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses focusing efforts to prevent gynecologic cancers.
Researchers need to think about treating patients earlier and determining how to prevent cancer from forming in the first place, she explains. There needs to be more examinations in high-risk groups and identify patients who are at risk for these gynecologic cancers—then work to help prevent a cancer diagnosis from occurring.
Progress is being made for therapies in the upfront and recurrent settings, but there needs to be more of a push in the prevention setting, she concludes.